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ABSTRACT 
The emergence of multi-drug resistant (MDR) strains of Mycobacterium tuberculosis is the main reason why 
tuberculosis (TB) continues to be a major health problem worldwide. It is urgent to discover novel anti-
mycobacterial agents based on new drug targets for the treatment of TB, especially MDR-TB. Tryptophan 
biosynthetic pathway, which is essential for the survival of M. tuberculosis and meanwhile absent in mammals, 
provides potential anti-TB drug targets. One of the promising drug targets in this pathway is anthranilate synthase 
component I (TrpE), whose role is to catalyze the conversion of chorismate to anthranilate using ammonia as 
amino source. Anthranilate synthase is an interesting target enzyme for antimicrobial activity due to its presence in 
microorganisms for the synthesis of the essential amino acid tryptophan.  In the present study three compounds 
Cannabigerolic acid, cannabinolic acid and adhumulone from Cannabis sativa have been used for insilio docking 
studies.  Inhibitory studies (invitro) of these compounds against Microorganism have reported earlier.  Our 
approach is to find out the compounds inhibiting the AS1 of MTB by insilico docking and also find out compounds 
having similar pharmacophore characters from ZINC database so that those compounds can be procured of 
synthesized in laboratory and used for AS1 inhibitor studies.  This study shows that AS can be used as a target 
enzyme to investigate the mode of action of our compounds in MTB. 
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1. INTRODUCTION 
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), remains one of the most devastating 
global diseases. About one-third of the world population is infected with M. tuberculosis and almost 5000 people 
die from TB everyday  (Corbett et al., 2003). Recently, long-term antibiotic therapy has led to the emergence and 
wide spread of multi-drug resistant (MDR) M. tuberculosis strains. Over 300,000 new cases of MDR-TB occur 
annually worldwide  (World Health Organization 2004) and meanwhile the treatment for MDR-TB is becoming less 
effective than ever. Therefore, discovery of novel anti-mycobacterial agents based on new drug targets is an 
urgent task to combat TB, especially MDR-TB. 
Anthranilate synthase (AS 1, EC 4.1.3.27), a member of tryptophan biosynthetic pathway, catalyzes the formation 
of anthranilate from chorismate and ammonia (or glutamine), which is the first committed step branching from the 
common aromatic amino acid (shikimate) pathway toward the biosynthesis of l-tryptophan. AS from 
microorganisms are made up of synthase component (TrpE) and glutamine amidotransferase component (TrpG), 
namely component I and component II, respectively  (Morollo and Eck 2001; Spraggon et al., 2001; Knochel et al., 
1999). TrpE is able to catalyze the synthesis of anthranilate with ammonia as the source of nitrogen atom 
independently  (Knochel et al., 1999; Ito  et al., 1969; Hankins and  Mills 1976). 
                         TrpE : Chorismate + ammonia ---------- anthranilate + pyruvate +water 
Moreover, the l-tryptophan binding site of AS is located on TrpE component  (Morollo and Eck 2001; Knochel et 
al., 1999; Zalkin and Kling 1968), therefore the inhibition of TrpE activity might cause the failure of tryptophan 
biosynthesis. In summary, TrpE is a promising drug target for the design of novel anti-TB drugs. 
The importance of computational approaches in designing selective ligands has become indispensable in the 
current drug design and discovery protocols. Homology modeling involves taking a known sequence with an 
unknown structure (target) and mapping it against a known structure (template) of one or several homologous 
proteins. The homology modeling is mainly based on the structural conservation of the framework regions 
between the members of a protein family. Proteins from different sources and sometimes diverse biological 
functions can have similar sequences. In general the process of homology modeling involves four sequential steps 
such as template selection, target-template alignment, model construction, and model assessment.  
2. MATERIALS AND METHODS 
2.1 Homology modeling 3D model building 
Homology modeling, also known as comparative modeling refers to constructing an atomic-resolution model of the 
"target"  protein  from its  amino acid sequence  and an experimental three-dimensional structure of a related 
homologous protein (the "template"). Homology modeling relies on the identification of one or more known protein 
structures likely to resemble the structure of the query sequence, and on the production of an alignment that maps 
residues in the query sequence to residues in the template sequence. The sequence alignment and template 
structure are then used to produce a structural model of the target. Because protein structures are more 
conserved than DNA sequences, detectable levels of sequence similarity usually imply significant structural 
similarity. 
Suppose you want to know the 3D structure of a target protein that has not been solved empirically by X-ray 
crystallography or NMR. You have only the sequence. If an empirically determined 3D structure is available for a 
sufficiently similar protein (50% or better sequence identity would be good), you can use software that arranges 
the backbone of your sequence identically to this template. This is called "homology modeling". It is, at best, 
moderately accurate for the positions of alpha carbons in the 3D structure, in regions where the sequence identity 
is high. It is inaccurate for the details of side chain positions and for inserted loops with no matching sequence in 
the solved structure. 
The query sequence from AS1 of mtb was submitted to domain fishing server Signal for prediction. The predicted 
domain was searched to find out the related protein structure to be used as a template by the BLAST (Basic Local 
Alignment Search Tool) program against PDB (Protein Databank). Sequence that showed maximum identity with 
high score and less e-value was aligned and 1I7Q of PDB structure of S. marcescens was used as a reference 
structure to build a 3D model for. The co-ordinates for the structurally conserved regions (SCRs) for AS1 of mtb 
were assigned from the template using multiple sequence alignment, based on the Needleman-Wunsch algorithm. 
The final structure obtained was analyzed by Ramachandran’s map using PROCHECK (Programs to check the 
Stereo chemical Quality of Protein Structures) and environment profile using ERRAT graph (Structure Evaluation 
server). This model was used for the identification of active site and for docking of the substrate with the enzyme.   
2.2 Active site Identification 
Active site of AS1 model of MTB was identified using CASTp. A new program, CASTp, for automatically locating 
and measuring protein pockets and cavities, is based on precise computational geometry methods, including 
alpha shape and discrete flow theory. CASTp identifies and measures pockets and pocket mouth openings, as 
     ISSN 22773061 
        
1238 | P a g e                                 J u l y  2 5 ,  2 0 1 3  
well as cavities. The program specifies the atoms lining pockets, pocket openings, and buried cavities; the volume 
and area of pockets and cavities; and the area and circumference of mouth openings. 
2.3 Docking method  
Docking was carried out using GOLD (Genetic Optimization of Ligand Docking) software which is based on 
genetic algorithm (GA). This method allows as partial flexibility of protein and full flexibility of ligand. The 
compounds are docked to the active site of the AS1 model of MTB. The interaction of these compounds with the 
active site residues are thoroughly studied using molecular mechanics calculations. After docking, the individual 
binding poses of each ligand were observed and their interactions with the protein were studied. The best and 
most energetically favorable conformation of each ligand was selected.   
2.3.1 Docking Studies.  
Protein preparation: The crystal structure of MTB AS1 is not yet available. So we have modeled the AS1 of MTB 
by using homology modeling. Hereafter we use the name of our target as AS1 model. For homology modeling 
purpose we have used 1I7q PDB ID of S. marcescens Anthranilate synthase as template.  
2.3.2 Gold Score fitness function  
Gold Score performs a force field based scoring function and is made up of four components: 1. Protein-ligand 
hydrogen bond energy (external H-bond); 2. Protein-ligand vander Waals energy (external vdw); 3. Ligand internal 
vander Waals energy (internal vdw); 4. Ligand intramolecular hydrogen bond energy (internal- H- bond). The 
external vdw score is multiplied by a factor of 1.375 when the total fitness score is computed. This is an empirical 
correction to encourage protein-ligand hydrophobic contact. The fitness function has been optimized for the 
prediction of ligand binding positions.  
GoldScore = S (hb_ext) + S (vdw_ext) + S (hb_int) + S (vdw_int)  
Where S (hb_ext) is the protein-ligand hydrogen bond score, S (vdw_ext) is the protein-ligand van der Waals 
score, S (hb_int) is the score from intramolecular hydrogen bond in the ligand and S (vdw_int) is  the score from 
intramolecular strain in the ligand. 
For each independent genetic algorithm (GA) run, a maximum of 100 000 operations were performed on a populat 
ion of 5 islands, each of 100 individuals.  Operator weights for crossover, mutation and migration were set to 95, 
95 and 10 respectively.  To allow for development of close contacts and poor hydrogen bonds occurring at the 
beginning of each GA run, the initial external Vander Waals (vdw) energies were cut off at 2.5k , where k is the 
depth of the vdw well between atoms i and j, and the maximum distance between a donor atom and a fitting point 
was set to 4 Å.  Ring flipping and internal hydrogen bonds were allowed.  The dockings were terminated after 25 
runs for each of the inhibitors. 
Various reports shown that Anthranlate synthase can be used as drug target and many researchers have 
designed inhibitors for Anthranilate synthase, but all are synthetic. In the present study we have used the natural 
compounds like cannabigerolic acid, cannabinolic acid, adhumulone extracted from plants. We have used these 
compounds as ligands and performed docking with AS1 model of MTB using GOLD software. Comparitively we 
docked the inhibitors like 4 methoxy benzoate and 2 methoxy benzoate also with AS1 model.  
2.3.3 ZINK 
The ZINC Database contains commercially available compounds for structure based virtual screening. It currently 
has about 20 million compounds that can simply be purchased. It is provided in ready-to-dock, 3D formats with 
molecules represented in biologically relevant forms. It is available in subsets for general screening as well as 
target-, chemotype- and vendor-focused subsets. ZINC is free for everyone to use and download at the 
website zinc.docking.org. This database and service is provided by the Shoichet Laboratory in the Department of 
Pharmaceutical Chemistry at the University of California San Francisco (UCSF). To cite ZINC, please reference: Irwin 
and Shoichet, J. Chem. Inf. Model. 2005; 45(1):177-82 PDF, DOI. We thank NIGMS for financial support 
(GM71896).  
The purpose of this search is the compounds used here are naturally available from plant source. Availability of 
these compounds in large scale is practically not feasible. So our approach is to search for compounds having 
similar pharmacophore features in ZINC database so that after docking they can directly purchased from the 
respective vendor and used for inhibitory studies on AS1 of MTB. 
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2.4 Different Natural compounds were checked for the docking with protein MTB 
AS1 as following 
S
n
o 
Name of the 
compounds 
Pubche
m ID 
SMILES 
1 Cannabigerolic 
acid 
644999
9 
CCCCCC1=CC(=C(C(=C1C(=O)
O)O)CC=C(C)CCC=C(C)C)O 
2 cannabinolic acid 308199
0 
CCCCCC1=CC2=C(C3=C(C=C
C(=C3)C)C(O2)(C)C)C(=C1C(=
O)O)O 
3 Adhumulone 193681  CCC(C)C(=C1C(=O)C(C(=O)C(
C1=O)(CC=C(C)C)O)CC=C(C)C
)O 
 
 
Fig1A:   Cannabigerolic acid                          Fig 1B:  Cannabinolic acid 
 
Fig 1C: Adhumulone 
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2.5 Different Synthetic compounds were checked for the docking with protein MTB 
AS1 as following 
 
        
Fig 2a: ZINC43059689                                                 Fig 2b:  ZINC40973021  
 
 
 
 
Fig 2c: ZINC38139497                                           Fig 2d:  ZINC13765599  
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                                                                                            Fig 2e: ZINC13340592  
3. RESULTS AND DISCUSSION 
3.1 Homology Modeling of MTB AS1 Protein 
A high level of sequence identity should guarantee more accurate alignment between the target sequence and 
template structure. In the results of BLAST search against PDB, 1I7Q of PDB structure of S. marcescens has a 
high level of sequence identity and the identity of the reference protein with the MTB AS1 are 48%.  
Sequences were aligned using the CLUSTAL W (1.82) multiple sequence alignment software “*” indicates that the 
amino acid residues in that column are ident ical in all sequences of the alignment “:” indicates that conserved 
residues have been ident ified amongst the sequences in the alignment “.”  indicates that semi-conserved 
substitutions have been observed amongst the sequences in the alignment. Residues coloured with red and the 
active site residues,  which are conserved in serratia and mtb proteins figure 3.  
MTB             --MHADLAATTSREDFR--LLAAEHRVVPVTRKVLADSETPLSAYRKLAANRPGTFLLES 56 
1I7Q_C          MNTKPQLTLLKVQASYRGDPTTLFHQLCGARPATLLLESAEINDKQNLQSLLVIDSALRI 60 
                   :.:*:  . : .:*    :  *::  .   .*  ..: :.  ::* :       *.  
MTB             AENGRSWSRWSFIGAGAPTALTVREGQ--AVWLGAVPK---------DAPTGGDP-LRAL 104 
1I7Q_C          TALGHTVSVQALTANGPALLPLLDEALPPEVRNQARPNGRELTFPAIDAVQDEDARLRSL 120 
                :  *:: *  :: . *..    : *.    *   * *:         **  . *. **:* 
MTB             QVTLELLATADRQSEPGLPPLSGGMVGFFAYDMVRRLERLPERAVDDLCLPDMLLLLATD 164 
1I7Q_C          SVFDALRTILTLVDSPADEREAVMLGGLFAYDLVAGFENLPALRQDQRC-PDFCFYLAET 179 
                .*   * :     ..*.    :  : *:****:*  :*.**    *: * **: : **   
MTB             VAAVDHHEGTITLIANAVNWNGTDERVDWAYDDAVARLDVMTAALGQPLPSTVATFSRPE 224 
1I7Q_C          LLVLDHQRGSARLQASVFSEQASEAQR------LQHRLEQLQAELQQP-PQPIPHQKLEN 232 
                : .:**:.*:  * *.... :.:: :          **: : * * ** *..:.  .  : 
MTB             PRHRAQRTVEEYGAIVEYLVDQIAAGEAFQVVPSQRFEMDTDVDPIDVYRILRVTNPSPY 284 
1I7Q_C          MQLSCNQSDEEYGAVVSELQEAIRQGEIFQVVPSRRFSLPCPA-PLGPYQTLKDNNPSPY 291 
                 :  .::: *****:*. * : *  ** ******:**.:   . *:. *: *: .***** 
MTB             MYLLQVPNSDGAVDFSIVGSSPEALVTVHEG--WATTHPIAGTRWRGRTDDE------DV 336 
1I7Q_C          MFFMQDD------DFTLFGASPESALKYDAGNRQIEIYPIAGTRPRGRRADGSLDLDLDS 345 
                *:::*        **::.*:***: :. . *      :****** ***  *       *  
MTB             LLEKELLADDKERAEHLMLVDLGRNDLGRVCTPGTVRVEDYSHIERYSHVMHLVSTVTGK 396 
1I7Q_C          RIELEMRTDHKELAEHLMLVDLARNDLARICQAGSRYVADLTKVDRYSFVMHLVSRVVGT 405 
                 :* *: :*.** *********.****.*:* .*:  * * ::::***.****** *.*. 
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MTB             LGEGRTALDAVTACFPAGTLSGAPKVRAMELIEEVEKTRRGLYGGVVGYLDFAGNADFAI 456 
1I7Q_C          LRADLDVLHAYQACMNMGTLSGAPKVRAMQLIAALRSTRRGSYGGRVGYFTAVRNLDTCI 465 
                *  .  .*.*  **:  ************:**  :..**** *** ***:  . * * .* 
MTB             AIRTALMRNGTAYVQAGGGVVADSNGSYEYNEARNKARAVLNAIAAAETLAAPGANRSGC 516 
1I7Q_C          VIRSAYVEDGHRTVQAGAGVVQDSIPEREADETRNKARAVLRAIATAHHAKEVF------ 519 
                .**:* :.:*   ****.*** **  . * :*:********.***:*.   
Figure 3: Clustal pair wise alignment,  
In the following study, we have chosen 1I7Q of PDB structure of S. marcescens as a reference structure for 
modeling domain. Coordinates from the reference protein 1I7Q of PDB structure of S. marcescens to the SCRs, 
structurally variable regions (SVRs), N-termini and C-termini were assigned to the target sequence based on the 
satisfaction of spatial restraints. In the modeller we will get a 20 PDB out of which we select a least energy. The 
energy unit will be in kilo joule. All side chains of the model protein were set by rotamers. The final stable structure 
of the MTB AS1 protein obtained is shown in Figure 4.  By the help of SPDBV. 
 
Figure 4:  Structure of the MTB AS1 protein 
3.2 Active site Identification of MTB AS1 
After the final model was built, the possible binding sites of MTB AS1 was searched based on the structural 
comparison of template and the model build and also with CASTP server and was shown in Figure 5. Since, MTB 
AS1 from Human and the 1I7Q of PDB structure of S. marcescens are well conserved in both sequence and 
structure; their biological function should be identical. In fact from the structure-structure comparison of template, 
final refined model of MTB AS1 domain using    34 SPDBV program.  
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Table 1 : Active Site Residues 
 
Sno Active  Site 
Residues in 
1I7Q 
Active  Site 
Residues in 
AS1 model 
1 GLU 361 GLU 348 
2 GLY 485 GLY 475 
3 GLY 328 GLY 324 
4 THR 329 THR 325 
5 GLU 498 GLU 488 
6 LYS 502 LYS 492 
7 ILE 326 ILE 322 
8 THR 425 THR 415 
9 GLU 309 GLU 303 
 
 
Fig: xx MTB AS 1 model showing Active site residues 
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Fig: 5 Active Site Residues of MTB AS1 model 
3.3 Docking of inhibitors with the active site of protein MTB AS1 
3.3.1 Natural copmponds 
Fitness   S(hb_ext) S(vdw_ext) S(hb_int) S(int)   time      File name                Ligand name 
-50.51    0.00     -14.05   0.00   -31.19   491.000  '.\gold_soln_3natural_m1_9.sdf'          '193681' 
-157.64   0.02     -97.43   0.00   -23.70   324.000 '.\gold_soln_3natural_m2_2.sdf'           '3081990' 
-22.47    1.42     4.10     0.00    -29.52  523.000   '.\gold_soln_3natural_m3_3.sdf'          '6449999' 
 
 
Fig 6a: Docking of molecule 1 pose 9 of 193681 – adhumulone 
 Interacting residues glu 361, Lys 357, Gly 485, thr 329, glu 498, Lys 502 
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Fig 6b: Docking of molecule 2 pose 2 of 3081990 – cannabinolic acid 
Interacting residues – Lys 502, Thr 329, Gly 328, Glu 498, Glu 361 
 
Fig 6c: Docking of molecule 3 pose 3 of - 6449999  – cannabigirolic acid 
Interacting residues – Thr 425, Glu 361, glu 498, thr 329, gly 328, ile 326 
In ZINC searching for adhumulone similar compounds we have got 40 compounds synthetic, In zinc searching for 
cannabigerolic acid similar compounds we have got 22 compounds, In zinc searching for cannabinolic acid similar 
compounds we have got 19 compounds. For 3 compounds from plant we could search total 81 compounds from 
zinc database, finally top 5 synthetic compounds taken for the docking studies. 
3.3.2 Top 5 Synthetic similar compounds 
Fitness        S(hb_ext)   S(vdw_ext)   S(hb_int)       S(int)  time                File name                                   Ligand 
name 
-31.80        0.00      -9.25       0.00     -19.08   137.000      '.\gold_soln_6449999 like_m17_1.sdf'             
'ZINC13340592' 
-88.14       0.00     -64.10       0.00    -316.16   167.000      '.\gold_soln_3081990 like_m17_4.sdf'             
'ZINC13765599' 
 -13.88       0.00      21.04       0.00     -15.04   157.000        '.\gold_soln_193681 like_m2_7.sdf'             
'ZINC38139497' 
 -31.81       0.00       4.39       0.00     -37.85   267.000       '.\gold_soln_6449999 like_m4_2.sdf'             
'ZINC40973021' 
 -37.52       0.03     -27.30       0.00    -939.74   141.001      '.\gold_soln_3081990 like_m15_5.sdf'             
'ZINC43059689' 
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Fig 7a. Docking of molecule 4 pose 2 644999 like compound from zinc 
Interacting residues are Gly 485, glu 498, glu 361, arg 469, thr 329 and his 398 
 
Fig  6b:  Docking of molecule17 pose 4 of 3081990 like compound from zinc 
Interacting residues Gly 328, His 398, Lys 357, Gly 485 
 
Fig 6c: Docking of molecule 2 pose 7 of 193681 like compound from zinc. 
Interacting residues Gly 328,Gly 485,Arg 469 
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Fig 6d. Docking of molecule 17 pose 1 of 644999 like compound from zinc 
Interacting residues Ile 326, Glu 361, Glu 498. 
 
Fig 6e:  Docking of molecule15 pose 5 of 3081990 like compound from zinc 
Interacting residues Gly 328, His 398, Lys 357, Gly 485 
Bioinformatics involves discovery, development and implementation of computational  algorithms and software 
tools that facilitate an understanding of the biological processes with  the goal to serve primarily healthcare sectors 
with several spin-offs. It is well-known that the key enzymes involved in the vital bio-chemical pathways of bacteria 
are potential targets for antibacterial drugs. The tryptophan biosynthetic pathway is a crucial metabolic pathway for 
the survival of M. tuberculosis  (Parish and Stoker 2002; Sassetti et al., 2003), and meanwhile does not exist in 
human (Xie et al., 2003). Thus, key enzymes involved in this pathway are potential drug targets for new anti-TB 
drugs. 
The purpose of this study is to identify the binding interaction having more binding energy towards the  MTB AS1. 
It is showed from the result of multiple sequence alignment (Clustal X) between template (S. marcescens) and 
query  (AS1 of mtb) that the alignment score was 481. The objective of this project is to generate the protein AS1 
of mtb and drugs targeted at specific docking of protein with inhibitor solution of the structure of     MTB AS1 
protein has led to the design of novel small molecule inhibitors. From the 20 pdb structures generated by the 
MODELLER we have selected least objective function structure for better inhibitory results. This structure was 
submitted to Ramachandran plot and it was identified that the generated model was reliable. This 3D structure 
was again improved through Molecular dynamics studies and finally active site residues were identified using 
Castp server.  The residues, GLU 348, GLY 475 GLY 324 THR 325 GLU 488 LYS 492 ILE 322 THR 415 GLU 303 
were involved in active site of the MTB AS1. According to data presented in results, it was observed that drugs 
inhibited AS1 of mtb. As mentioned by the data above, it suggests form testing of these drugs at experimental 
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investigation.  There is now great excitement in the field of TB research with the development of a MTB AS1 
protein inhibitor.   
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